Hitoshi Matsuda
Directeur/Bestuurslid bij GNI Hong Kong Ltd.
Actieve functies van Hitoshi Matsuda
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Shanghai Genomics, Inc.
 Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Comptroller/Controller/Auditor | 01-07-2013 | - |
| GNI-EPS Pharmaceuticals, inc. | Directeur/Bestuurslid | 01-07-2013 | - |
GNI Hong Kong Ltd.
 GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services GNI Hong Kong Ltd. engages in property management. The company was founded on July 31, 2013 and is headquartered in Hong Kong. | Directeur/Bestuurslid | 01-07-2013 | - |
Loopbaan van Hitoshi Matsuda
Eerdere bekende functies van Hitoshi Matsuda
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Directeur/Bestuurslid | 01-07-2013 | - |
| GNI GROUP LTD. | Directeur/Bestuurslid | 01-07-2013 | - |
| Operationeel Directeur | 01-07-2013 | - |
Opleiding van Hitoshi Matsuda
| Keio University | Graduate Degree |
Statistieken
Internationaal
| China | 4 |
| Japan | 3 |
| Hongkong | 2 |
Operationeel
| Director/Board Member | 4 |
| Chief Operating Officer | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GNI GROUP LTD. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Shanghai Genomics, Inc.
Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Health Technology |
| GNI-EPS Pharmaceuticals, inc. | |
GNI Hong Kong Ltd.
GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services GNI Hong Kong Ltd. engages in property management. The company was founded on July 31, 2013 and is headquartered in Hong Kong. | Commercial Services |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Health Technology |
- Beurs
- Insiders
- Hitoshi Matsuda
- Ervaring
